Group 1 - Liu Pharmaceutical Group plans to repurchase shares worth between 100 million and 200 million yuan, with a maximum repurchase price of 25.70 yuan per share [1] - Dongshan Precision intends to invest up to 1 billion USD to build a high-end printed circuit board project to meet the long-term demand for high-end printed circuit boards in emerging scenarios such as AI [1] - Bomaike reported a net profit of 12.39 million yuan for the first half of the year, a year-on-year decline of 80.42% [2] Group 2 - Western Mining achieved a net profit of 1.869 billion yuan in the first half of the year, a year-on-year increase of 15% [2] - Fuliwang expects a net loss of approximately 17 million yuan for the first half of the year, a decrease of 137.12% compared to the same period last year [2] - Digital Certification anticipates a net loss of between 80 million and 96 million yuan for the first half of the year, compared to a loss of 29.25 million yuan in the same period last year [3] Group 3 - Shanghai Construction reported a net profit of 710 million yuan for the first half of the year, a year-on-year decrease of 14.04% [5] - Funneng Co. achieved a net profit of 1.337 billion yuan in the first half of the year, a year-on-year increase of 12.48% [6] - Tengda Construction's total contract amount for the first half of the year decreased by 17.55% year-on-year [7] Group 4 - Fudan Fuhua decided to terminate the public transfer of a 28% stake in a subsidiary due to the lack of a deposit from potential buyers [9] - Fulei Ant's subsidiary has decided to cease operations due to intense competition in the photovoltaic industry and ongoing losses [11] - Dongfang Ocean's subsidiary received a medical device registration certificate for a folic acid testing kit [14] Group 5 - Huayu Pharmaceutical's subsidiary received overseas listing approvals for several products [16] - Feima International received a performance commitment compensation of 437 million yuan from its controlling shareholder [16] - Guangshen Railway signed a cooperation agreement for the Guangzhou East Station renovation project with a total investment of approximately 16.66 billion yuan [16] Group 6 - Anhui Construction won the bid for the S68 Jingde to Jixi Expressway project with an estimated total investment of 5.7 billion yuan [18] - China Communications Construction Company signed new contracts worth 991.054 billion yuan in the first half of the year, a year-on-year increase of 3.14% [19] - Kehui Co. plans to use up to 70 million yuan of idle funds for cash management [22] Group 7 - Biological Shares' subsidiary received a clinical trial approval for a cat mRNA vaccine, the first of its kind in China [23] - Ruipu Biological received a clinical trial approval for a pig mRNA vaccine, which is the first economic animal mRNA vaccine in China [24] - Nanjing New Hundred's major assets were judicially frozen due to liquidity debt crisis faced by its controlling shareholder [27] Group 8 - Changshu Bank plans to merge three village banks and establish branches, pending shareholder approval [28] - Yong'an Pharmaceutical plans to reduce its holdings by up to 2.6323 million shares [29] - Zhujiang Co. received approval from the Shanghai Stock Exchange for a stock issuance to specific targets [31] Group 9 - Sanyangma's subsidiary signed a 120 million yuan procurement contract for sensor products [33] - Jintou City Development plans to purchase a villa property for approximately 7.1854 million yuan [35] - Yuanli Co. intends to acquire 100% of Tongsheng Co. through a combination of cash and stock issuance [36] Group 10 - Xin'an Century's controlling shareholder plans to reduce holdings by up to 2.22% of the company's shares [36] - Fute Technology plans to raise up to 528 million yuan through a private placement for various projects [36] - Helen Piano's actual controller is set to change, with stock resuming trading [37] Group 11 - Weiergao expects a net profit increase of 12.55% to 30.87% for the first half of the year [38] - Saiwei Microelectronics plans to transfer up to 18% of its shares through an agreement [40] - Yongli Co. intends to acquire a 22.75% stake in a subsidiary [42] Group 12 - ST Xiachuang plans to publicly transfer a 20% stake in Guangdong Yuweiji [43] - Dema Technology's shareholders plan to transfer 778.84 million shares through an inquiry [45] - Zhongshi Technology's shareholders plan to reduce holdings by up to 2.86% of the company's shares [46] Group 13 - Wufang Optoelectronics' controlling shareholder plans to reduce holdings by up to 0.93% of the company's shares [48] - Fusenmei's chairman has been detained, temporarily unable to fulfill his duties [49] - Reliable Co.'s shareholders plan to reduce holdings by a total of up to 2.63% of the company's shares [51] Group 14 - Gao Neng Environment plans to repurchase shares worth between 100 million and 150 million yuan [53]

Group 1 - The core point of the news is that Derma Technology (688360.SH) plans to transfer a total of 7,788,393 shares, representing 2.9530% of its total share capital, through a shareholder inquiry transfer before its initial public offering [1][2] - The shareholders involved in the transfer include Derma Investment, Chuangde Investment, and Huzhou Ligoo, with the transfer primarily driven by their own funding needs [2][3] - The transfer will be conducted as a non-public transfer, and the shares acquired through this inquiry transfer cannot be transferred within six months [3] Group 2 - Derma Technology was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on June 2, 2020, with an issuance of 21,419,150 shares at a price of 25.12 yuan per share, raising a total of 538.05 million yuan [3] - The company plans to use the funds raised for projects including digital workshop construction, intelligent sorting system upgrades, and working capital [3] - In 2023, Derma Technology completed the acquisition of 100% equity in Jiangsu Moandi Technology Co., Ltd., with the transaction valued at 55.15 million yuan, reflecting a 358.59% appreciation [4][5] Group 3 - The acquisition involved issuing shares and cash, with 50% of the transaction price paid in shares and 50% in cash [6][7] - The transaction will not create new related party transactions with the controlling shareholder or its affiliates [7][8] - Moandi specializes in the R&D, production, and sales of core components for logistics sorting equipment, which aligns with Derma Technology's focus on intelligent logistics systems and key equipment [9]

Core Viewpoint - The announcement details the share transfer plan of Demar Technology Group Co., Ltd., involving a total of 7,788,393 shares, which represents 2.9530% of the total share capital, primarily driven by the shareholders' funding needs [3][5][6]. Shareholder Information - The transferring shareholders include Demar Investment, Chuangde Investment, and Huzhou Ligoo, collectively holding over 5% of the company's shares and acting in concert [2][3]. - Demar Investment is the controlling shareholder, while Chuangde Investment and Huzhou Ligoo serve as employee stock ownership platforms [3]. Transfer Details - The total number of shares to be transferred is 7,788,393, accounting for 2.9530% of the total share capital, with the transfer motivated by the shareholders' funding needs [5][6]. - The transfer will be conducted through a non-public method, not involving centralized bidding or block trading [5][6]. Pricing Mechanism - The minimum transfer price will be determined based on the requirements of the Shanghai Stock Exchange and will consider the shareholders' funding needs [6][7]. - The pricing will follow a priority system based on subscription price, subscription quantity, and the time of receipt of subscription bids [7]. Investor Eligibility - Eligible investors for the share transfer include institutional investors with appropriate pricing capabilities and risk tolerance, such as securities companies, fund management companies, and qualified foreign investors [7].

向特定机构投资者询价转让股份相关资格的核查意见 关于德马科技集团股份有限公司股东 中国国际金融股份有限公司（以下简称"中金公司"）受德马科技集团股份 有限公司（以下简称"德马科技"）股东湖州德马投资咨询有限公司、湖州力固 管理咨询有限公司、湖州创德投资咨询合伙企业（有限合伙）（以下简称"德马 投资"、"湖州力固"、"创德投资"或"出让方"）委托，组织实施本次德马科技 股东向特定机构投资者询价转让（以下简称"本次询价转让"）。 根据《关于在上海证券交易所设立科创板并试点注册制的实施意见》《科创 板上市公司持续监管办法（试行）》《上海证券交易所科创板股票上市规则》《上 海证券交易所科创板上市公司自律监管指引第 4 号——询价转让和配售》（以下 简称"《询价转让和配售指引》"）等相关规定，中金公司对参与本次询价转让股 东的相关资格进行了核查。 本次询价转让的委托情况、出让方相关资格的核查情况及核查意见如下： 一、本次询价转让的委托 2025 年 7 月 22 日，中金公司收到出让方关于本次询价转让的委托，委托中 金公司组织实施本次询价转让。 中国国际金融股份有限公司 （3）本次询价转让出让方德马投资为公司控股股东， ...

证券代码：688360 证券简称：德马科技 公告编号：2025-025 德马科技集团股份有限公司 股东询价转让计划书 湖州德马投资咨询有限公司（以下简称"德马投资"）、湖州创德投资咨询 合伙企业（有限合伙）（以下简称"创德投资"）、湖州力固管理咨询有限公司 （以下简称"湖州力固"）（以下合称"出让方"）保证向德马科技集团股份有 限公司（以下简称"公司"、"德马科技"）提供的信息内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其真实性、准确性和完整性依法承担法律责 任。 公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： 一、拟参与转让的股东情况 （一）出让方的名称、持股数量、持股比例 出让方委托中国国际金融股份有限公司（以下简称"中金公司"）组织实施 本次询价转让。截至 2025 年 7 月 20 日，出让方所持首发前股份的数量、占总股 本比例情况如下： 1 拟参与德马科技首发前股东询价转让（以下简称"本次询价转让"）的 股东为德马投资、创德投资、湖州力固； 出让方拟转让股份的总数为 7,788,393 股，占德马科技总股本的比例为 2.9530%； 本次询价转让为非公开转 ...

Investment Rating - The report maintains a "Recommended" investment rating for the humanoid robot industry [7]. Core Insights - The humanoid robot concept index increased by 4.57% from July 13 to July 18, 2025, outperforming the CSI 300 index by 3.48 percentage points. Year-to-date, the humanoid robot index has risen by 44.57%, surpassing the CSI 300 index by 38.34 percentage points [2][13]. - Key companies in the humanoid robot sector are receiving significant capital support, with notable investments and IPO preparations indicating a robust growth trajectory [4][5]. Weekly Market Review - From July 13 to July 18, 2025, the humanoid robot concept index rose by 4.57%, while the year-to-date performance shows a 44.57% increase compared to the CSI 300 index [2][13]. - Among A-share humanoid robot stocks, Zhongdali De had the highest weekly increase at +30.62%, while Haosen Intelligent saw the largest decline at -11.73% [19]. Weekly Hotspot Review Policy Developments - Guangdong Province is accelerating the development of the embodied robot industry, focusing on future industries such as biomanufacturing and quantum technology [3][22]. - Shanghai's government has approved the "Moli Ju Shen" action plan to establish a highland for embodied intelligence industry development [3][22]. Product and Technology Iteration - UBTECH's Walker S2 has introduced a world-first autonomous battery swap system, enabling 24/7 operation [3][24]. - The Beijing Humanoid Robot Innovation Center launched the first one-stop public service platform for embodied intelligence in China [3][24]. Investment and Financing - Zhiyuan Robotics completed a strategic financing round supported by Charoen Pokphand Group, enhancing its market reach [4][25]. - Blue Dot Touch Technology announced nearly 100 million RMB in Series B financing to accelerate humanoid robot industrialization [4][25]. - Yushu Technology has initiated IPO counseling, with its controlling shareholder holding approximately 35% of the company [5][27]. Key Company Announcements - New Era plans to launch a general controller for embodied intelligence in 2025 and collaborate with Haier on smart manufacturing solutions [4][28]. - Bertley intends to invest 198 million RMB in a partnership focused on high-growth unlisted companies in the humanoid robot sector [4][29]. - Chipsea Technology is exploring applications in robotic electronic skin and six-dimensional force sensors [4][29].

Summary of Dematech's Conference Call Industry and Company Overview - **Company**: Dematech - **Industry**: Robotics, specifically focusing on humanoid robots and automation solutions Key Points and Arguments 1. **Strategic Focus on Humanoid Robots**: Dematech is strategically positioning itself in the humanoid robot sector, emphasizing both upstream components (like screws and motors) and downstream collaborations with robot manufacturers to enhance performance in real-world applications [2][6][8] 2. **Screw Technology as a Core Component**: The company identifies screw technology as a critical component for humanoid robots due to its high load capacity, longevity, and precision, aiming to integrate this technology into their core offerings [2][7] 3. **Logistics as a Target Market**: Dematech believes that logistics scenarios are ideal for humanoid robots due to their repetitive tasks and general applicability, making it a prime market for entry [2][10][11] 4. **Collaboration with Robot Manufacturers**: The company has established close partnerships with various humanoid robot manufacturers, including Zhiyuan, to enhance training and deployment capabilities [2][9][12] 5. **Data-Driven Autonomous Work**: Dematech is focused on achieving data-driven autonomous operations, having trained nearly 30 humanoid robots and planning to explore data trading models to further business development [2][14] Additional Important Insights 1. **Global Market Strategy**: Dematech is implementing a "local for local" strategy by establishing factories in Europe, Australia, and the U.S. to mitigate trade barriers and tariffs [4][22] 2. **Product Launch Plans**: The company plans to launch new products in 2025, including lightweight and efficient components, as well as AI-integrated smart conveyors and sorting machines [4][27] 3. **Challenges in Data Collection**: The company faces significant challenges in data collection for humanoid robots, as existing data is limited and often requires extensive cleaning and annotation [17][18] 4. **Training and Adaptation of Humanoid Robots**: Training humanoid robots for logistics tasks is a complex and lengthy process, requiring substantial data accumulation and testing to ensure effectiveness [19][16] 5. **Impact of Tariffs on Business**: Dematech has managed to mitigate the impact of tariffs through local manufacturing and by diversifying its market presence beyond the U.S. to regions with lower tariffs [21][23] Future Plans and Goals 1. **Expansion of Strategic Partnerships**: The company aims to deepen collaborations with existing partners and explore new partnerships to enhance its humanoid robot offerings [15] 2. **Focus on Automation Solutions**: Dematech's long-term goal is to create fully automated logistics systems, integrating humanoid robots and automation technologies to provide comprehensive solutions [19] 3. **Market Penetration in Overseas Markets**: The company is prioritizing overseas markets for its humanoid robots, particularly in regions with high automation demand, such as Japan and Europe [24][25][26]

Summary of Key Points Core Viewpoint - On July 18, a total of 16 stocks on the Sci-Tech Innovation Board (STAR Market) experienced block trading, with a cumulative transaction amount of 171 million yuan, indicating active trading activity in this sector [1]. Group 1: Trading Activity - A total of 31 block trades were recorded, with a cumulative trading volume of 4.8367 million shares [1]. - The stock with the highest transaction amount was Haitan Ruisheng, which had 9 block trades totaling 38.30 million shares and a transaction amount of 38.30 million yuan [1]. - Other notable stocks in terms of transaction amounts included Guangyun Technology and Fuchuang Precision, with transaction amounts of 24.9162 million yuan and 20.9360 million yuan, respectively [1]. Group 2: Price and Discount Analysis - The stocks that experienced the highest discount rates relative to their closing prices included Qingyun Technology, Weixin Bio, and Guangyun Technology, with discount rates of 19.48%, 17.25%, and 14.95%, respectively [1]. - The average increase for the stocks involved in block trading was 2.55%, with the top gainers being Dema Technology, Qingyun Technology, and Huasheng Lithium, which saw increases of 14.74%, 7.90%, and 7.22% respectively [1]. Group 3: Institutional Participation - Among the block trades, 12 transactions involved institutional buyers or sellers, with the highest buying amounts for Haitan Ruisheng, Guangyun Technology, and Qingyun Technology, at 27.70 million yuan, 11.2276 million yuan, and 7.579 million yuan, respectively [2]. - In terms of net capital flow, six stocks saw net inflows, with Dema Technology, Huasheng Lithium, and Qingyun Technology leading with net inflows of 51.1035 million yuan, 33.284 million yuan, and 32.1246 million yuan, respectively [2].

Core Viewpoint - The scarcity of real-world data is a significant constraint on the development of the embodied intelligence industry, and data collection centers may provide a solution to this issue [1][4]. Group 1: Data Collection Initiatives - Dematech and Zhiyuan Robotics have established the world's first logistics training factory for humanoid robots to collect data in real logistics scenarios [1]. - The Hefei City humanoid robot data collection pre-training site was launched in June, and the Pacini humanoid super data factory began operations this year [1][3]. - The establishment of data collection centers has accelerated since the second half of last year, with companies like Zhiyuan Robotics and Pacini leading the way [3]. Group 2: Data Collection Challenges - The humanoid robots require extensive data for training, with a single scenario potentially needing millions of data points, but the industry lacks high-quality, standardized data [4]. - Two main approaches to overcome the data scarcity have emerged: generating simulation data for training and building large-scale data collection centers for high-quality real-world data [4]. - The industry is currently facing challenges such as hardware solutions not being standardized and the issue of data silos, which increases data collection costs [7][8]. Group 3: Government Involvement - Local governments are also investing in data collection centers, with initiatives like the national and local co-built humanoid robot innovation centers [5]. - Government-led data collection centers typically serve as public service platforms, with collected data being made available to local robot companies once sufficient data is accumulated [5]. Group 4: Market Dynamics - The humanoid robot industry is expected to see significant data collection activity in the next two years, particularly in industrial applications [7]. - A complete data collection solution typically includes robots, hardware, software, cloud data processing services, and model training platforms, with costs ranging from 400,000 to 500,000 yuan [5].

关于公司高级管理人员辞职的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 德马科技集团股份有限公司（以下简称"公司"）董事会于近日收到公司副 总经理吴中华先生递交的辞职报告，吴中华先生因个人原因申请辞去公司副总经 理职务。辞去副总经理职务后，吴中华先生不再担任公司其他岗位职务。根据《中 华人民共和国公司法》《德马科技集团股份有限公司章程》的规定，吴中华先生 关于公司副总经理的辞职申请自辞职报告送达公司董事会时生效，具体情况如下： 一、高级管理人员离任情况 (一) 提前离任的基本情况 证券代码：688360 证券简称：德马科技 公告编号：2025-024 | 是否继续 | 是否存 | 原定任 | 在上市公 | 在未履 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 离任原 | 姓名 | 离任职务 | 离任时间 | 期到期 | 司及其控 | 行完毕 | 因 | | | 日 | 股子公司 | 的公开 | 任职 | 承诺 ...